Myriad Genetics (MYGN) announced that Ben Wheeler has been promoted to Chief Financial Officer, effective August 16, 2025. Ben has been with Myriad for more than 13 years, joining the Company in December 2011 as assistant controller and advancing through leadership roles including vice president, corporate controller; senior vice president, accounting; and since 2022, chief financial officer, operations. Scott Leffler, who has served as Chief Financial Officer since January 2024, will transition to a consulting role serving the CEO and the Board of Directors through September 2, 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYGN:
- Myriad Genetics’ Earnings Call: Growth Amid Challenges
- Disney reports Q3 beat and NFL deal, Uber authorizes $20B buyback: Morning Buzz
- Myriad Genetics Updates 2025 Revenue Guidance Amid Growth
- Hold Rating Maintained for Myriad Genetics Amid Mixed Performance and Strategic Challenges
- Myriad Genetics reports Q2 adjusted EPS 5c, consensus (1c)